Viewing Study NCT01569750


Ignite Creation Date: 2025-12-24 @ 5:08 PM
Ignite Modification Date: 2026-02-24 @ 5:46 AM
Study NCT ID: NCT01569750
Status: COMPLETED
Last Update Posted: 2017-08-22
First Post: 2012-03-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study Combining Ibrutinib With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With CD20-Positive B-Cell Non Hodgkin Lymphoma
Sponsor:
Organization: